Can a quick office procedure unblock stuffy noses without surgery?
NCT ID NCT07772505
First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time
Summary
This trial compares two procedures done in the clinic to treat nasal blockage caused by enlarged turbinates—the small structures inside the nose. One uses radiofrequency energy to shrink the tissue, while the other uses an instrument to push the turbinates aside. Adults with moderate-to-severe nasal obstruction who haven't improved with medication will be randomly assigned to one of the two procedures. The study tracks changes in nasal obstruction symptoms and turbinate size over six months to see which approach works better.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Radiofrequency ablation or lateralization of the inferior turbinates, both office-based procedures to reduce turbinate size and improve nasal airflow.
- What this could lead to
- If successful, this could identify which clinic-based procedure is more effective and safer for relieving nasal obstruction, offering a quicker alternative to surgery.
- What could go wrong
- This is a small, early-stage comparative study. Both procedures carry risks like pain, bleeding, crusting, and symptom recurrence, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
54 people
The number who actually took part.
- Started
-
Nov 2020
- Finished
-
Jun 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Bilateral inferior turbinate hypertrophy, Grade 3 or 4 (25% Inferior Turbinate Classification System) Age more than 18 years NOSE score more than 30 On conventional pharmacological therapy for more than 3 months Exclusion Criteria: Severe deviated nasal septum or caudal dislocation Nasal polyposis Nasal valve disorder Allergy or contraindication to Marcaine (bupivacaine) with adrenaline, or to Co-Phenylcaine
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Inferior turbinates hypertrophy are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tengku Ampuan Rahimah Hospital
Klang, Selangor, 41200, Malaysia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New Triple-Action pill takes on cold and flu symptoms
- New nasal spray aims to unblock stuffy noses fast
- Could a simple nose clip help millions breathe easier and smell again?
- Virtual reality could replace pills for pain during ENT procedures
- New gel could keep your nose clear longer
- New gel promises Ultra-Fast relief for chronic throat and nose sufferers